Doctors rebound from COVID-19 limitations, settle into ‘new normal’
Results of a second AOA Health Policy Institute survey on the pandemic’s impact on optometry show practices are better off now than in April but still nowhere near pre-COVID-19 levels.
Marijuana dispensaries still blow smoke over glaucoma effects
Half of cannabis dispensaries responding to a recent survey admit to recommending marijuana products for glaucoma, but even patients aren’t buying it—at least the IOP-lowering claims.
VSP policy change may violate states’ patient protection laws
VSP reimbursement changes, which take effect Sept. 1, may run counter to states’ laws as the AOA and affiliates challenge policies that could negatively affect patient care.
AFOS celebrates five decades of delivering eye care through federal services
Its first organized meeting attracted 34 attendees; today, its membership is about 985.
Aug. 5 deadline to apply for grants for community eye health and vision care projects
Healthy Eyes Healthy Children grants spread awareness and increase comprehensive vision services.
Conjunctival lymphangiectasia: Possible signs of things unseen
Researchers suggest these generally uncommon eye surface lesions may help disclose undiagnosed Fabry disease, predict disease severity and possibly even function as biomarkers for treatment efficacy.